When and how to start and discontinue corticosteroid treatment in palliative care?
Maciej Bączyk
Advances in Palliative Medicine 2004;3(2):171-178.
open access
Vol 3, No 2 (2004): Polish Palliative Medicine
Artykuły poglądowe
Published online: 2004-04-09
Abstract
Glucocorticosteroids are widely used in palliative care. In the case of specific indications, they are the drugs
of choice and we assume a priori the need for long-term administration, even over several months, until the
patient’s death. In the case of non-specific indications, administration should be scheduled over approximately
3–4 weeks, because in many patients, after the initial improvement, the therapeutic effect decreases despite
continued use, while there is a growing risk of undesirable side effects and lasting HPA axis suppression. In
patients receiving long-term oral corticosteroid treatment, even a considerable deterioration of the patient’s
overall condition does not excuse failure to replace it with parenteral corticosteroid administration, both for
specific and non-specific indications.
Abstract
Glucocorticosteroids are widely used in palliative care. In the case of specific indications, they are the drugs
of choice and we assume a priori the need for long-term administration, even over several months, until the
patient’s death. In the case of non-specific indications, administration should be scheduled over approximately
3–4 weeks, because in many patients, after the initial improvement, the therapeutic effect decreases despite
continued use, while there is a growing risk of undesirable side effects and lasting HPA axis suppression. In
patients receiving long-term oral corticosteroid treatment, even a considerable deterioration of the patient’s
overall condition does not excuse failure to replace it with parenteral corticosteroid administration, both for
specific and non-specific indications.